Point-of-care testing hubWhat is point-of-care testing (POCT)?Point-of-care testing (POCT), also known as near-patient testing (NPT), are tests performed outside the laboratory – usually at the bedside or in wards utilising point-of-care testing devices. POCT can produce test results within minutes and are generally portable. Technology improvements, a growing need to expand access to testing for diverse test settings and users, are driving a decentralisation trend in in-vitro diagnostics (IVD) testing. Clearstate offers point-of-care testing and device market data, forecasts, and trend predictions to give you the insight to adjust your business strategy to the increasing demand for affordable POC tests.
Covid-19: point-of-care vs. lab-based testingCovid-19 testing has emerged as a top priority for clinical laboratories and many IVD players. SARS-CoV-2 tests make up more than half of Asia-Pacific’s (APAC’s) total infectious disease diagnostics market. Read more
Winning market share in the rise of connected blood glucose testing at Chinese hospitalsIn China, the use of connected point-of-care (POC) blood glucose testing will play an increasingly important role in diabetes management at hospitals. China has the largest number of diabetes cases in the world. Besides patients hospitalised for diabetes complications, the country also has a large population of inpatients with high blood glucose levels which has been associated with increased hospitalisation expenses. Read more
Three test areas to watch in point-of-care infectious diseases testing in developing countriesIn this infographic, EIU Healthcare picks out high-growth test areas in infectious diseases to watch based on data and forecasts from IVD Gateway, shedding light on where and how companies can help expand access to POC testing in developing countries. Read more
report by clearstateThe Future of Point-of-Care (POC) Testing in Asia-Pacific (APAC)Point-of-care (POC) diagnostics is expected to be one of the fastest-growing major in-vitro diagnostics (IVD) market segments in Asia-Pacific (APAC). Learn more
report by clearstateThe future of point-of-care testing in Latin AmericaAs Latin America (LATAM) experiences a shift towards decentralised IVD testing and greater constraints on fiscal budgets and healthcare systems, IVD companies will have to adapt their market strategy to meet the region’s increased demand for affordable point-of-care (POC) tests, particularly around infectious diseases. Learn more
Clearstate newsletterSign up to our newsletter for insights into key market data, trends and developments across IVD and Surgical segments from our specialists and analysts. Sign up now